Management

Uday Patel

Vice President
Regulatory Affairs

Uday Patel joined Aviragen Therapeutics as Vice President of Regulatory Affairs in June 2014.

Mr. Patel has been a partner and key member of senior management and scientific project teams in successful start-ups to clinical stage organizations. Mr. Patel’s background includes international experience in program management, clinical operations, regulatory affairs, analytical development and quality assurance. Most recently, he served as Vice President of Regulatory Affairs and Quality Assurance at Inhibitex, Inc. from 2010 to 2012. He was responsible for development and implementation of regulatory strategy for various clinical programs and management of QA tasks in clinical development of infectious disease therapies. Prior to joining Inhibitex, he was Vice President of Regulatory/Quality at Peptimmune from 2004 to 2010, responsible for execution of regulatory and quality initiatives focused on autoimmune indications and metabolic diseases.

Mr. Patel received a B.S. degree in Biochemistry from Suffolk University and Master of Liberal Arts (ALM) degree in Biology from Harvard University. Mr. Patel has received regulatory affairs certification (RAC) for US and EU from the regulatory affairs professionals society (RAPS).

Log In

Create an account